Celltrion | 068270 - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.01M 175K 2026-03
Avita Medical AUD -10.41M 742K 2025-12
Celltrion KRW 12.9B 822.77M 2026-03
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
IQVIA Holdings USD 2.6B 2.03B 2026-06
Moderna USD -815M 573M 2026-06
Organon & Co USD 266M 49M 2026-03
Revvity USD 126.14M 43.36M 2026-06
Tectonic Therapeutic USD -27.3M 5.78M 2026-03
Viatris USD -20.2M 137.3M 2026-03
Xeris Pharmaceuticals USD 7.92M 8.86M 2026-03